0

Diabetes Collection
 21-40 of 100 Articles
ACP Journal Club |  15 January 2013
A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years
Jeffrey Mahon, MD, MSc
Ann Intern Med. 2013;158(2):JC4. doi:10.7326/0003-4819-158-2-201301150-02004
ACP Journal Club |  20 November 2012
Review: Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes
Eugene C. Corbett Jr., MD, MACP
Ann Intern Med. 2012;157(10):JC5-6. doi:10.7326/0003-4819-157-10-201211200-02006
ACP Journal Club |  16 October 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Sean F. Dinneen, MD; Máire O’Donnell, PhD
Ann Intern Med. 2012;157(8):JC4-11. doi:10.7326/0003-4819-157-8-201210160-02011
ACP Journal Club |  16 October 2012
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes
Juan P. Brito, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2012;157(8):JC4-7. doi:10.7326/0003-4819-157-8-201210160-02007
ACP Journal Club |  18 September 2012
Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-11. doi:10.7326/0003-4819-157-6-201209180-02011
ACP Journal Club |  18 September 2012
Glargine did not reduce CV events more than standard care in patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-10. doi:10.7326/0003-4819-157-6-201209180-02010
ACP Journal Club |  21 February 2012
The optimal HbA1c cutpoint to screen for diabetes in the emergency department was 6.0%
Eddy S. Lang, MD
Ann Intern Med. 2012;156(4):JC2-11. doi:10.7326/0003-4819-156-4-201202210-02011
ACP Journal Club |  17 January 2012
Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
Gabriela Prutsky, MD; Juan Pablo Domecq, MD; Apostolos Tsapas, MD, PhD
Ann Intern Med. 2012;156(2):JC1-7. doi:10.7326/0003-4819-156-2-201201170-02007
ACP Journal Club |  20 December 2011
Patients with rheumatoid arthritis and those with diabetes mellitus had a similar increased risk for myocardial infarction
Roland Staud, MD
Ann Intern Med. 2011;155(12):JC6-11. doi:10.7326/0003-4819-155-12-201112200-02011
ACP Journal Club |  20 December 2011
Review: Insulin to maintain normoglycemia within 24 hours of ischemic stroke does not reduce death or dependency
Paul G. Wasielewski, MD; Ken Uchino, MD
Ann Intern Med. 2011;155(12):JC6-5. doi:10.7326/0003-4819-155-12-201112200-02005
ACP Journal Club |  20 December 2011
Review: Intensive glucose lowering does not reduce mortality in type 2 diabetes
Vijaykumar Lingegowda, MD, MSEd, FASN
Ann Intern Med. 2011;155(12):JC6-4. doi:10.7326/0003-4819-155-12-201112200-02004
ACP Journal Club |  15 November 2011
Review: Pregabalin and other drugs reduce pain in patients with painful diabetic neuropathy
Michael Tanner, MD, FACP
Ann Intern Med. 2011;155(10):JC5-8. doi:10.7326/0003-4819-155-10-201111150-02008
ACP Journal Club |  15 November 2011
Review: Lowering systolic BP to ≤ 135 mm Hg reduces CV events in type 2 diabetes/IFG/IGT
Michael E. Farkouh, MD, MSc
Ann Intern Med. 2011;155(10):JC5-3. doi:10.7326/0003-4819-155-10-201111150-02003
ACP Journal Club |  18 October 2011
Review: Evidence for the effectiveness of interventions to prevent foot ulcers in patients with diabetes is limited
Dara L. Eckerle Mize, MD; Gunjan Y. Gandhi, MD, MSc
Ann Intern Med. 2011;155(8):JC4-8. doi:10.7326/0003-4819-155-8-201110180-02008
ACP Journal Club |  18 October 2011
Review: Intensive-dose statin therapy increases incident diabetes compared with moderate-dose therapy
Elizabeth Barrett-Connor, MD
Ann Intern Med. 2011;155(8):JC4-7. doi:10.7326/0003-4819-155-8-201110180-02007
ACP Journal Club |  20 September 2011
Protocol-based nurse management of type 2 diabetes did not differ from usual GP care for HbA1c levels
Timothy Kenealy, MD, PhD; Nicolette Sheridan, RN, PhD, MPH
Ann Intern Med. 2011;155(6):JC3-7. doi:10.7326/0003-4819-155-6-201109200-02007
ACP Journal Club |  16 August 2011
Review: Rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes
Prakash Deedwania, MD
Ann Intern Med. 2011;155(4):JC2-12. doi:10.7326/0003-4819-155-4-201108160-02012
ACP Journal Club |  16 August 2011
Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints
Juan Pablo Domecq, MD; Gabriela Prutsky, MD; Victor M. Montori, MD
Ann Intern Med. 2011;155(4):JC2-4. doi:10.7326/0003-4819-155-4-201108160-02004
ACP Journal Club |  19 July 2011
13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria
David R. Gutknecht, MD
Ann Intern Med. 2011;155(2):JC1-13. doi:10.7326/0003-4819-155-2-201107190-02013
ACP Journal Club |  19 July 2011
Review: Intensive insulin therapy does not reduce mortality but increases severe hypoglycemia in hospitalized patients
Stephen M. Pastores, MD, FACP, FCCP, FCCM
Ann Intern Med. 2011;155(2):JC1-12. doi:10.7326/0003-4819-155-2-201107190-02012
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)